Ann: Remestemcel Clinical and Potency Studies Presented at Tandem, page-69

  1. 17,581 Posts.
    lightbulb Created with Sketch. 2529
    When other posters respond in a manner that tries to put down or discredit the person rather than the argument that has been put forward it shows a lack of confidence in their own ability to respond to the facts. So they try to respond in a manner that distracts people from the substance of the argument and discourages the opposition from continuing. And Phaedrus pretty much almost reframes things to avoid directly responding to the item in question.

    Really it just shows how rattled and how unconfident they are that the FDA will grant approval for any of the applications. That's why they repeatedly make the same statements about how certain they are that the FDA will grant approval for aGVHD, accelerated approval for use in CHF and low back pain. It's a kind of expression of hopes and self reassurance that everything will be fine and the company will be "bigger than CSL".

    So don't take the arrogant jibes personally. They just don't want to have their bubble dreams pricked by reality
    Last edited by whytee: 05/03/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.39
Change
0.110(4.82%)
Mkt cap ! $3.059B
Open High Low Value Volume
$2.31 $2.43 $2.30 $15.10M 6.360M

Buyers (Bids)

No. Vol. Price($)
3 9186 $2.38
 

Sellers (Offers)

Price($) Vol. No.
$2.40 22000 3
View Market Depth
Last trade - 16.11pm 23/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.